Logo image of EXL.DE

EXASOL AG (EXL.DE) Stock Fundamental Analysis

Europe - FRA:EXL - DE000A0LR9G9 - Common Stock

3.43 EUR
-0.01 (-0.29%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, EXL scores 5 out of 10 in our fundamental rating. EXL was compared to 103 industry peers in the Software industry. While EXL has a great health rating, there are worries on its profitability. EXL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXL had positive earnings in the past year.
In the past year EXL had a positive cash flow from operations.
EXL had negative earnings in 4 of the past 5 years.
EXL had negative operating cash flow in 4 of the past 5 years.
EXL.DE Yearly Net Income VS EBIT VS OCF VS FCFEXL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

EXL has a Return On Assets of 1.19%. This is comparable to the rest of the industry: EXL outperforms 48.54% of its industry peers.
EXL's Return On Equity of 5.02% is in line compared to the rest of the industry. EXL outperforms 49.51% of its industry peers.
Industry RankSector Rank
ROA 1.19%
ROE 5.02%
ROIC N/A
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
EXL.DE Yearly ROA, ROE, ROICEXL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

EXL's Profit Margin of 0.58% is in line compared to the rest of the industry. EXL outperforms 46.60% of its industry peers.
Looking at the Gross Margin, with a value of 93.86%, EXL belongs to the top of the industry, outperforming 94.17% of the companies in the same industry.
EXL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.58%
GM 93.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
EXL.DE Yearly Profit, Operating, Gross MarginsEXL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

EXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EXL has about the same amount of shares outstanding.
EXL has more shares outstanding than it did 5 years ago.
EXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXL.DE Yearly Shares OutstandingEXL.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EXL.DE Yearly Total Debt VS Total AssetsEXL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 5.14 indicates that EXL is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.14, EXL is doing good in the industry, outperforming 66.99% of the companies in the same industry.
There is no outstanding debt for EXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.14
ROIC/WACCN/A
WACC7.4%
EXL.DE Yearly LT Debt VS Equity VS FCFEXL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

EXL has a Current Ratio of 23.06. This indicates that EXL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 23.06, EXL belongs to the top of the industry, outperforming 98.06% of the companies in the same industry.
A Quick Ratio of 23.06 indicates that EXL has no problem at all paying its short term obligations.
EXL's Quick ratio of 23.06 is amongst the best of the industry. EXL outperforms 98.06% of its industry peers.
Industry RankSector Rank
Current Ratio 23.06
Quick Ratio 23.06
EXL.DE Yearly Current Assets VS Current LiabilitesEXL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 102.68% over the past year.
EXL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.76%.
EXL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.89% yearly.
EPS 1Y (TTM)102.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.91%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%16.25%

3.2 Future

The Earnings Per Share is expected to grow by 200.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXL will show a quite strong growth in Revenue. The Revenue will grow by 10.51% on average per year.
EPS Next Y750%
EPS Next 2Y318.33%
EPS Next 3Y200%
EPS Next 5YN/A
Revenue Next Year7.2%
Revenue Next 2Y7.25%
Revenue Next 3Y8.3%
Revenue Next 5Y10.51%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXL.DE Yearly Revenue VS EstimatesEXL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
EXL.DE Yearly EPS VS EstimatesEXL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

3

4. Valuation

4.1 Price/Earnings Ratio

EXL is valuated quite expensively with a Price/Earnings ratio of 343.00.
Compared to the rest of the industry, the Price/Earnings ratio of EXL is on the same level as its industry peers.
EXL is valuated expensively when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 39.95, which means the current valuation is very expensive for EXL.
EXL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.77. EXL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 343
Fwd PE 39.95
EXL.DE Price Earnings VS Forward Price EarningsEXL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

EXL's Enterprise Value to EBITDA ratio is in line with the industry average.
EXL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 76.64
EV/EBITDA 39.16
EXL.DE Per share dataEXL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXL's earnings are expected to grow with 200.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y318.33%
EPS Next 3Y200%

0

5. Dividend

5.1 Amount

EXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXASOL AG

FRA:EXL (9/15/2025, 7:00:00 PM)

3.43

-0.01 (-0.29%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners13.19%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap92.20M
Analysts83.33
Price Target5.2 (51.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)21.43%
EPS NY rev (3m)21.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.93%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 343
Fwd PE 39.95
P/S 2.33
P/FCF 76.64
P/OCF 66.67
P/B 20.18
P/tB 32.26
EV/EBITDA 39.16
EPS(TTM)0.01
EY0.29%
EPS(NY)0.09
Fwd EY2.5%
FCF(TTM)0.04
FCFY1.3%
OCF(TTM)0.05
OCFY1.5%
SpS1.47
BVpS0.17
TBVpS0.11
PEG (NY)0.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.19%
ROE 5.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.58%
GM 93.86%
FCFM 3.04%
ROA(3y)-34.86%
ROA(5y)-43.4%
ROE(3y)-152.02%
ROE(5y)-136.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.71%
F-Score8
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 8.38%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion 70.11%
Profit Quality 524.64%
Current Ratio 23.06
Quick Ratio 23.06
Altman-Z 5.14
F-Score8
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)7.45%
Cap/Depr(5y)49.4%
Cap/Sales(3y)0.53%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.91%
EPS Next Y750%
EPS Next 2Y318.33%
EPS Next 3Y200%
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y13.01%
Revenue growth 5Y12.89%
Sales Q2Q%16.25%
Revenue Next Year7.2%
Revenue Next 2Y7.25%
Revenue Next 3Y8.3%
Revenue Next 5Y10.51%
EBIT growth 1Y97.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3850.5%
EBIT Next 3Y335.34%
EBIT Next 5YN/A
FCF growth 1Y118.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.98%
OCF growth 3YN/A
OCF growth 5Y-9.08%